"De-Extinction" Company Colossal Launches Form Bio to Maximize Tech
Colossal Biosciences recently made headlines for its “de-extinction” efforts with the thylacine, commonly known as the Tasmania tiger. On Tuesday, the company announced it is spinning out its computational platform into a new company called Form Bio, thanks to a $30 million investment deal to accelerate this technology.